Produktname:1-Methyl-4-oxo-7-(trifluoromethyl)-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylic acid
IUPAC Name:1-methyl-4-oxo-7-(trifluoromethyl)-4H,5H-imidazo[1,2-a]quinoxaline-2-carboxylic acid
- CAS:164329-75-3
- Molekulare Formel:C13H8F3N3O3
- Reinheit:97%
- Katalognummer:CM222405
- Molekulargewicht:311.22
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:164329-75-3
- Molekulare Formel:C13H8F3N3O3
- Schmelzpunkt:-
- SMILES-Code:O=C(C1=C(C)N2C(C(NC3=C2C=CC(C(F)(F)F)=C3)=O)=N1)O
- Dichte:
- Katalognummer:CM222405
- Molekulargewicht:311.22
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.